Free Trial

Minerva Neurosciences (NERV) Short Interest Ratio & Short Volume

Minerva Neurosciences logo
$1.70 -0.11 (-6.30%)
As of 11:44 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Minerva Neurosciences Short Interest Data

Minerva Neurosciences (NERV) has a short interest of 26,100 shares, representing 0.48% of the float (the number of shares available for trading by the public). This marks a -54.13% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.6, indicating that it would take 0.6 days of the average trading volume of 28,382 shares to cover all short positions.

Current Short Interest
26,100 shares
Previous Short Interest
56,900 shares
Change Vs. Previous Month
-54.13%
Dollar Volume Sold Short
$40,194.00
Short Interest Ratio
0.6 Days to Cover
Last Record Date
March 15, 2025
Outstanding Shares
6,993,000 shares
Float Size
5,440,000 shares
Short Percent of Float
0.48%
Today's Trading Volume
18,036 shares
Average Trading Volume
28,382 shares
Today's Volume Vs. Average
64%
Short Selling Minerva Neurosciences?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Minerva Neurosciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

NERV Short Interest Over Time

NERV Days to Cover Over Time

NERV Percentage of Float Shorted Over Time

Remove Ads

Minerva Neurosciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/15/202526,100 shares $40,194.00 -54.1%0.5%0.6 $1.54
2/28/202556,900 shares $95,023.00 +35.5%1.1%1.3 $1.67
2/15/202542,000 shares $82,740.00 +101.0%0.8%1 $1.97
1/31/202520,900 shares $48,279.00 +5.0%0.4%0.6 $2.31
1/15/202519,900 shares $42,586.00 +34.5%0.4%0.6 $2.14
12/31/202414,800 shares $32,856.00 +94.7%0.3%0.6 $2.22
12/15/20247,600 shares $16,796.00 -20.0%0.1%0.3 $2.21
11/30/20249,500 shares $21,422.50 -59.4%0.2%0.6 $2.26
11/15/202423,400 shares $51,480.00 +229.6%0.4%1.5 $2.20
10/31/20247,100 shares $17,004.50 -1.4%0.1%0.4 $2.40
10/15/20247,200 shares $19,152.00 -25.0%0.1%0.4 $2.66
9/30/20249,600 shares $25,632.00 +24.7%0.2%0.5 $2.67
9/15/20247,700 shares $22,715.00 -29.4%0.1%0.4 $2.95
8/31/202410,900 shares $29,866.00 -10.7%0.2%0.5 $2.74
8/15/202412,200 shares $32,330.00 -11.0%0.2%0.3 $2.65
7/31/202413,700 shares $40,689.00 -31.8%0.3%0.4 $2.97
7/15/202420,100 shares $67,536.00 +38.6%0.4%0.6 $3.36
6/30/202414,500 shares $46,255.00 -5.8%0.3%0.4 $3.19
6/15/202415,400 shares $51,282.00 -51.4%0.3%0.4 $3.33
5/31/202431,700 shares $80,835.00 +16.1%0.6%0.8 $2.55
5/15/202427,300 shares $70,297.50 +7.1%0.5%0.3 $2.58
4/30/202425,500 shares $60,177.45 -16.4%0.5%0.2 $2.36
4/15/202430,500 shares $73,810.00 -24.3%0.6%0.3 $2.42
3/31/202440,300 shares $103,974.00 +5.2%0.7%0.3 $2.58
3/15/202438,300 shares $106,857.00 -68.7%0.7%0.3 $2.79
2/29/2024122,400 shares $326,808.00 +416.5%2.3%1.1 $2.67
2/15/202423,700 shares $222,780.00 +25.4%0.5%0.3 $9.40
1/31/202418,900 shares $159,705.00 +33.1%0.4%0.5 $8.45
1/15/202414,200 shares $105,790.00 -55.6%0.3%0.5 $7.45
12/31/202332,000 shares $196,800.00 -30.6%0.7%1.3 $6.15
12/15/202346,100 shares $297,345.00 -37.4%1.0%2.3 $6.45
11/30/202373,600 shares $577,760.00 -6.5%1.5%3.6 $7.85
11/15/202378,700 shares $408,453.00 +53.7%1.6%4.2 $5.19
10/31/202351,200 shares $246,784.00 +4.5%1.1%2.4 $4.82
10/15/202349,000 shares $279,790.00 -17.0%1.0%1.8 $5.71
9/30/202359,000 shares $407,100.00 -20.3%1.2%1.3 $6.90
9/15/202374,000 shares $575,720.00 -7.9%1.5%0.1 $7.78
8/31/202380,300 shares $672,111.00 -21.1%1.9%0.1 $8.37
8/15/2023101,800 shares $911,110.00 -17.0%2.4%0.1 $8.95
7/31/2023122,700 shares $1.17 million +16.6%2.9%0.1 $9.51
This trading frustration almost made me quit (Ad)

This happened to me time and time again, and I wanted no more of it. That’s exactly why I set out to refine my strategy… And with the help of my good friend Nate, we have done exactly that… Now, I cannot promise future returns or against losses, but the real trades so far have been nothing but astounding. Turning my once 69% win rate, into 83.3% on real trades in the last two months. And instead of just telling you, I want to SHOW you.

And you can check it out right here.
7/15/2023105,200 shares $1.27 million -75.8%3.1%0.1 $12.07
6/30/2023434,000 shares $3.97 million +540.1%12.8%0.4 $9.14
6/15/202367,800 shares $496,296.00 -49.8%1.5%0.3 $7.32
5/31/2023135,000 shares $805,950.00 -54.6%2.9%0.7 $5.97
5/15/2023297,300 shares $1.91 million +263.5%6.4%1.6 $6.44
4/30/202381,800 shares $229,040.00 -22.7%1.8%0.5 $2.80
4/15/2023105,800 shares $241,224.00 +27.2%2.3%1.7 $2.28
3/31/202383,200 shares $133,120.00 -8.0%1.8%1.1 $1.60
3/15/202390,400 shares $157,296.00 -20.1%2.0%1 $1.74
2/28/2023113,200 shares $244,512.00 +15.9%2.5%1.2 $2.16
2/15/202397,700 shares $230,572.00 -4.0%2.2%1 $2.36
1/31/2023101,800 shares $243,302.00 -41.5%2.2%0.6 $2.39
1/15/2023174,100 shares $386,502.00 +20.2%3.8%1 $2.22
12/30/2022144,900 shares $230,391.00 -26.6%3.2%0.5 $1.59
12/15/2022197,300 shares $554,413.00 -21.5%4.3%0.6 $2.81
11/30/2022251,300 shares $889,602.00 +0.8%5.5%0.6 $3.54
11/15/2022249,200 shares $859,740.00 +79.3%5.5%0.1 $3.45
10/31/2022139,000 shares $368,350.00 -57.2%3.1%0 $2.65
10/15/2022324,600 shares $4.36 million -43.4%7.1%0.1 $13.43
9/30/2022573,400 shares $5.29 million -47.4%12.6%0.1 $9.23
9/15/20221,090,000 shares $9.88 million -31.9%24.0%0.2 $9.06
8/31/20221,600,000 shares $18.05 million +787.4%35.2%0.3 $11.28
8/15/2022180,300 shares $558,930.00 +254.2%4.0%0.1 $3.10
7/31/202250,900 shares $136,412.00 -8.9%1.0%0.1 $2.68
7/15/202255,900 shares $169,936.00 +12.9%1.1%1.9 $3.04
6/30/202249,500 shares $163,845.00 -8.5%1.0%1.8 $3.31
6/15/202254,100 shares $178,746.40 -78.4%N/A2.4 $3.30
5/31/2022250,500 shares $100,200.00 +11.3%0.6%1.8 $0.40
5/15/2022225,100 shares $86,663.50 -0.9%0.6%2.5 $0.39
4/30/2022227,200 shares $115,872.00 -5.5%0.6%2.3 $0.51
4/15/2022240,500 shares $187,349.50 -21.7%0.6%2.3 $0.78
3/31/2022307,000 shares $254,871.40 -13.9%0.7%2.7 $0.83
3/15/2022356,500 shares $238,855.00 -2.1%0.9%2.1 $0.67
2/28/2022364,300 shares $257,195.80 -15.5%0.9%1.8 $0.71
2/15/2022431,200 shares $340,648.00 -16.8%1.1%1.4 $0.79
1/31/2022518,500 shares $427,969.90 +16.3%1.3%1.2 $0.83
1/15/2022445,900 shares $372,281.91 +18.5%1.1%0.9 $0.83
12/31/2021376,300 shares $301,416.30 -19.8%0.9%0.7 $0.80
12/15/2021469,300 shares $407,352.40 -22.5%1.1%0.7 $0.87
11/30/2021605,600 shares $588,037.60 -13.0%1.5%0.9 $0.97
11/15/2021696,200 shares $898,098.00 -62.0%1.7%1 $1.29
10/29/20211,830,000 shares $2.56 million +1.1%4.5%3 $1.40
10/15/20211,810,000 shares $2.44 million -8.6%4.4%2.9 $1.35
9/30/20211,980,000 shares $3.45 million -3.4%4.8%3 $1.74
9/15/20212,050,000 shares $3.42 million -6.0%5.0%3 $1.67
8/31/20212,180,000 shares $4.01 million +5.3%5.3%3.5 $1.84
8/13/20212,070,000 shares $3.50 million +6.2%5.0%3.3 $1.69
7/30/20211,950,000 shares $3.59 million -3.5%4.7%1.1 $1.84
7/15/20212,020,000 shares $4.08 million -2.9%4.9%1.2 $2.02
6/30/20212,080,000 shares $4.83 million -37.9%5.1%1.3 $2.32
This trading frustration almost made me quit (Ad)

This happened to me time and time again, and I wanted no more of it. That’s exactly why I set out to refine my strategy… And with the help of my good friend Nate, we have done exactly that… Now, I cannot promise future returns or against losses, but the real trades so far have been nothing but astounding. Turning my once 69% win rate, into 83.3% on real trades in the last two months. And instead of just telling you, I want to SHOW you.

And you can check it out right here.
6/15/20213,350,000 shares $9.38 million No Change8.1%2.2 $2.80
5/28/20213,350,000 shares $9.88 million -34.7%8.1%2.3 $2.95
5/14/20215,130,000 shares $13.80 million +85.9%N/A3.5 $2.69
4/30/20212,760,000 shares $6.71 million +9.1%N/A6.5 $2.43
4/15/20212,530,000 shares $6.15 million +5.0%N/A6.1 $2.43
3/31/20212,410,000 shares $7.09 million -1.6%N/A3.8 $2.94
3/15/20212,450,000 shares $8.18 million No ChangeN/A3.5 $3.34
2/26/20212,450,000 shares $7.89 million +14.0%N/A3 $3.22
2/12/20212,150,000 shares $7.63 million +6.4%6.0%2.4 $3.55
1/29/20212,020,000 shares $6.42 million +6.3%5.8%2.3 $3.18
1/15/20211,900,000 shares $5.11 million -11.6%5.4%2.2 $2.69
12/31/20202,150,000 shares $5.14 million +7.5%6.1%3.4 $2.39
12/15/20202,000,000 shares $5.30 million -0.5%5.7%3.3 $2.65
11/30/20202,010,000 shares $8.06 million -19.9%5.7%3.2 $4.01
11/15/20202,510,000 shares $8.94 million -14.0%7.2%4.8 $3.56
10/30/20202,920,000 shares $9.46 million -12.6%8.2%5.2 $3.24
10/15/20203,340,000 shares $11.22 million -5.7%9.8%4.7 $3.36
9/30/20203,540,000 shares $11.26 million -7.8%10.3%4.2 $3.18
9/15/20203,840,000 shares $12.67 million -13.1%11.2%3.6 $3.30
8/31/20204,420,000 shares $14.06 million -3.9%12.9%3.4 $3.18
8/14/20204,600,000 shares $15.59 million -14.0%13.6%1.3 $3.39
7/31/20205,350,000 shares $18.62 million -17.8%16.2%1.5 $3.48
7/15/20206,510,000 shares $21.48 million -7.0%20.7%1.9 $3.30
6/30/20207,000,000 shares $24.36 million -0.3%22.2%2.1 $3.48
6/15/20207,020,000 shares $25.83 million +118.7%22.3%2.3 $3.68
5/29/20203,210,000 shares $11.91 million +20.2%10.2%1.2 $3.71
5/15/20202,670,000 shares $33.56 million -5.3%8.5%5.3 $12.57
4/30/20202,820,000 shares $25.30 million -5.4%9.0%7.2 $8.97
4/15/20202,980,000 shares $19.49 million +5.7%9.5%8.5 $6.54
3/31/20202,820,000 shares $23.12 million -3.2%9.0%7.8 $8.20

NERV Short Interest - Frequently Asked Questions

What is Minerva Neurosciences' current short interest?

Short interest is the volume of Minerva Neurosciences shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 26,100 shares of NERV short. 0.48% of Minerva Neurosciences' shares are currently sold short. Learn More on Minerva Neurosciences' current short interest.

What is a good short interest ratio for Minerva Neurosciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NERV shares currently have a short interest ratio of 1.0. Learn More on Minerva Neurosciences's short interest ratio.

Which institutional investors are shorting Minerva Neurosciences?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Minerva Neurosciences: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Minerva Neurosciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.48% of Minerva Neurosciences' floating shares are currently sold short.

Is Minerva Neurosciences' short interest increasing or decreasing?

Minerva Neurosciences saw a decline in short interest in March. As of March 15th, there was short interest totaling 26,100 shares, a decline of 54.1% from the previous total of 56,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Minerva Neurosciences' float size?

Minerva Neurosciences currently has issued a total of 6,993,000 shares. Some of Minerva Neurosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Minerva Neurosciences currently has a public float of 5,440,000 shares.

How does Minerva Neurosciences' short interest compare to its competitors?

0.48% of Minerva Neurosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Minerva Neurosciences: Virpax Pharmaceuticals, Inc. (1.86%), X4 Pharmaceuticals, Inc. (5.15%), Aadi Bioscience, Inc. (6.58%), Werewolf Therapeutics, Inc. (6.04%), Immix Biopharma, Inc. (2.24%), Century Therapeutics, Inc. (8.70%), Iterum Therapeutics plc (4.52%), Outlook Therapeutics, Inc. (19.15%), OKYO Pharma Limited (0.89%), Verrica Pharmaceuticals Inc. (8.48%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks.

What does it mean to sell short Minerva Neurosciences stock?

Short selling NERV is an investing strategy that aims to generate trading profit from Minerva Neurosciences as its price is falling. NERV shares are trading down $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Minerva Neurosciences?

A short squeeze for Minerva Neurosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NERV, which in turn drives the price of the stock up even further.

How often is Minerva Neurosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NERV, twice per month. The most recent reporting period available is March, 15 2025.




This page (NASDAQ:NERV) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners